Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Int J Mol Sci ; 21(9)2020 Apr 25.
Article de Anglais | MEDLINE | ID: mdl-32344823

RÉSUMÉ

Iron overload is related to leukemia transformation in myelodysplastic syndrome (MDS) patients. Siderophores help to transport iron. Type 2-hydroxybutyrate dehydrogenase (BDH2) is a rate-limiting factor in the biogenesis of siderophores. Using qRT-PCR, we analyze BDH2mRNA expression in the bone marrow (BM) of 187 MDS patients, 119 de novo acute myeloid leukemia (AML) patients, and 43 lymphoma patients with normal BM. Elevated BDH2mRNA expression in BM is observed in MDS patients (n = 187 vs. 43, normal BM; P = 0.009), and this is related to ferritin levels. Patients with higher BDH2 expression show a greater risk of leukemia progression (15.25% vs. 3.77%, lower expression; P = 0.017) and shorter leukemia-free-survival (medium LFS, 9 years vs. 7 years; P = 0.024), as do patients with a ferritin level ≥350 ng/mL. Additionally, we investigate the mechanisms related to the prognostic ability of BDH2 by using BDH2-KD THP1. The cell cycle analysis, surface markers, and special stain studies indicate that BDH2-KD induces differentiation and decreases the growth rate of THP1 cells, which is associated with the retardation of the cell cycle. Moreover, many genes, including genes related to mitochondrial catabolism, oncogenes, tumor suppressor genes, and genes related to cell differentiation and proliferation influence BDH2-KD THP1 cells. Herein, we demonstrate that BDH2 is involved in cell cycle arrest and the inhibition of differentiation in malignant cells. Furthermore, the high BDH2 expression in MDS patients could be suggestive of a poor prognostic factor. This study provides a foundation for further research on the roles of BDH2 and iron metabolism in the pathogenesis of MDS.


Sujet(s)
Moelle osseuse/anatomopathologie , Régulation de l'expression des gènes/génétique , Hydroxybutyrate dehydrogenase/physiologie , Leucémie aigüe myéloïde/enzymologie , Syndromes myélodysplasiques/enzymologie , Préleucémie/enzymologie , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Apoptose/génétique , Moelle osseuse/métabolisme , Points de contrôle du cycle cellulaire/génétique , Différenciation cellulaire/génétique , Femelle , Ferritines/sang , Régulation de l'expression des gènes dans la leucémie , Humains , Hydroxybutyrate dehydrogenase/biosynthèse , Hydroxybutyrate dehydrogenase/génétique , Leucémie aigüe myéloïde/génétique , Leucémie aigüe myéloïde/anatomopathologie , Lipocaline-2/biosynthèse , Lipocaline-2/génétique , Mâle , Adulte d'âge moyen , Syndromes myélodysplasiques/sang , Syndromes myélodysplasiques/génétique , Syndromes myélodysplasiques/anatomopathologie , Protéines tumorales/biosynthèse , Protéines tumorales/sang , Protéines tumorales/génétique , Protéines tumorales/physiologie , Préleucémie/génétique , Préleucémie/anatomopathologie , Pronostic , Survie sans progression , Interférence par ARN , ARN messager/biosynthèse , ARN tumoral/biosynthèse , Petit ARN interférent/génétique , Cellules THP-1 , Jeune adulte
2.
Alcohol Alcohol ; 28(4): 431-6, 1993 Jul.
Article de Anglais | MEDLINE | ID: mdl-8104400

RÉSUMÉ

The time-course of ketone body concentrations, the activities of enzymes of their utilization as well as the activities of acetyl-CoA synthetase and ATP-citrate lyase were studied in the liver, brain and heart of rats receiving ethanol for 40 days (3 g/kg, intragastrally). Ethanol increased the concentration of 3-hydroxybutyrate 3 hr following the last ethanol treatment in the blood and tissues investigated and that of acetoacetate in the liver with raised acetoacetyl-CoA synthetase activity in all three tissues. The activities of acetyl-CoA-generating enzymes were, however, increased only in the liver and heart. Chronic alcohol intoxication diminished the activities of ketone body utilizing enzymes (3-hydroxybutyrate dehydrogenase and 3-oxo acid-CoA transferase) in the heart but not in the brain. The data obtained indicate both disturbed ketone body utilization and increased importance of acetate produced from ethanol as an energy source in the heart during long-term ethanol treatment.


Sujet(s)
Intoxication alcoolique/enzymologie , Alcoolisme/enzymologie , Encéphale/enzymologie , Corps cétoniques/sang , Foie/enzymologie , Myocarde/enzymologie , Acetyl-coA C-acetyltransferase/physiologie , Animaux , Coenzyme A ligases/physiologie , Coenzyme A-transferases/physiologie , Hydroxybutyrate dehydrogenase/physiologie , Mâle , Mitochondries/enzymologie , Rats
4.
Arch Biochem Biophys ; 244(2): 671-7, 1986 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-3947086

RÉSUMÉ

The involvement of tyrosyl residues in the function of D-beta-hydroxybutyrate dehydrogenase, a lipid-requiring enzyme, has been investigated by using several tyrosyl modifying reagents, i.e., N-acetylimidazole, a hydrophilic reagent, and 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole and tetranitromethane, two hydrophobic reagents. Modification of the tyrosyl residues highly inactivates the derived enzyme: Treatment of the enzyme with 7-chloro-4-nitro[14C]benzo-2-oxa-1,3-diazole leads to an absorbance at 380 nm and to an incorporation of about 1 mol of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole per polypeptide chain for complete inactivation. Inactivation by N-acetylimidazole induces a decrease in absorbance at 280 nm which can be reversed by hydroxylamine treatment. On the other hand, the ligands of the active site, such as methylmalonate, a pseudosubstrate, and NAD+ (or NADH), do not protect the enzyme against inactivation. In contrast, the presence of phospholipids strongly protects the enzyme against hydrophobic reagents. Finally, previous modification of the enzyme with N-acetylimidazole does not affect the incorporation of 7-chloro-4-nitro[14C]benzo-2-oxa-1,3-diazole while modification with tetranitromethane does. These results indicate the existence of two classes of tyrosyl residues which are essential for enzymatic activity, and demonstrate their location outside of the active site. One of these residues appears to be located close to the enzyme-phospholipid interacting sites. These essential residues may also be essential for maintenance of the correct active conformation.


Sujet(s)
Hydroxybutyrate dehydrogenase/analyse , Phospholipides/physiologie , Tyrosine/physiologie , Animaux , Hydroxybutyrate dehydrogenase/antagonistes et inhibiteurs , Hydroxybutyrate dehydrogenase/physiologie , Techniques in vitro , Cinétique , Conformation des protéines , Rats , Relation structure-activité , Tyrosine/analyse
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...